Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Breast Neoplasms 9Neoplasms 5Anxiety Disorders 5Pain 3Lung Neoplasms 3Depression 3Sleep Initiation and Maintenance Disorders 2Polycystic Ovary Syndrome 2Obesity 2Neuropathy, Painful 2Fatigue 2Chronic Pain 2Uterine Cervical Neoplasms 1Stress, Psychological 1Squamous Intraepithelial Lesions 1Smoking 1Signs and Symptoms 1Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1Overweight 1Ovarian Neoplasms 1Neurobehavioral Manifestations 1Multiple Myeloma 1Motor Activity 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Follicular 1Lymphoma 1Hot Flashes 1

Interventions

Cyclophosphamide 41Peripheral Blood Stem Cell Transplantation 40fludarabine phosphate 36Whole-Body Irradiation 27Mycophenolic Acid 27Tacrolimus 23Busulfan 23Cyclosporine 22Antilymphocyte Serum 20Etoposide 17Methotrexate 16Filgrastim 16Melphalan 14romidepsin 13Radiotherapy 13Flow Cytometry 12Methylprednisolone 10Brentuximab Vedotin 10Therapeutics 9Psychiatric Rehabilitation 9Lenalidomide 8pembrolizumab 7fludarabine 7Sirolimus 7Rituximab 7Bortezomib 7Bexarotene 7mogamulizumab 6Polymerase Chain Reaction 6Gemcitabine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma, T-Cell, Cutaneous × Mindfulness-Based Stress Reduction × Clear all
NCT03174808 2019-11-27

Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)

Yale University

Phase NA Terminated
3 enrolled
DermatologicLymphoid

Anxiety Disorders, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡